4//SEC Filing
Harshbarger Benjamin 4
Accession 0001104659-18-009352
CIK 0000827809other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 7:01 AM ET
Size
5.9 KB
Accession
0001104659-18-009352
Insider Transaction Report
Form 4
Harshbarger Benjamin
General Counsel and Secretary
Transactions
- Award
Stock Option (Right to Buy)
2018-02-12+45,000→ 45,000 totalExercise: $4.44Exp: 2028-02-12→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]Each option has an exercise price equal to the closing price of a common share of the Issuer on the Nasdaq Global Select Market on the grant date.
- [F2]The option shall vest and become exercisable in three equal annual installments on February 12, 2019, February 12, 2020, and February 12, 2021.
Documents
Issuer
NOVELION THERAPEUTICS INC.
CIK 0000827809
Entity typeother
Related Parties
1- filerCIK 0001653133
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 7:01 AM ET
- Size
- 5.9 KB